A tool for evaluating heterogeneity in avidity of polyclonal antibodies

Diversity in specificity of polyclonal antibody (pAb) responses is extensively investigated in vaccine efficacy or immunological evaluations, but the heterogeneity in antibody avidity is rarely probed as convenient tools are lacking. Here we have developed a polyclonal antibodies avidity resolution...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Kan Li, Michael Dodds, Rachel L. Spreng, Milite Abraha, Richard H. C. Huntwork, Lindsay C. Dahora, Tinashe Nyanhete, Sheetij Dutta, Ulrike Wille-Reece, Erik Jongert, Katie J. Ewer, Adrian V. S. Hill, Celina Jin, Jennifer Hill, Andrew J. Pollard, S. Munir Alam, Georgia D. Tomaras, S. Moses Dennison
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	dissociation rate avidity binning polyclonal antibodies Typhim RTS,S/AS01
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1049673/full

Similar Items

IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model
by: Lindsay C. Dahora, et al.
Published: (2019-11-01)

TitrationAnalysis: a tool for high throughput binding kinetics data analysis for multiple label-free platforms [version 1; peer review: 3 approved]
by: Richard H.C. Huntwork, et al.
Published: (2023-07-01)

TitrationAnalysis: a tool for high throughput binding kinetics data analysis for multiple label-free platforms [version 2; peer review: 3 approved]
by: Richard H.C. Huntwork, et al.
Published: (2024-06-01)

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection
by: Kelly E. Seaton, et al.
Published: (2021-08-01)

GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.
by: Lin Lin, et al.
Published: (2024-11-01)

Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates
by: Georgia D. Tomaras, et al.
Published: (2013-12-01)

Bringing the path toward an HIV-1 vaccine into focus.
by: Cesar J Lopez Angel, et al.
Published: (2020-09-01)

Improving peptide-MHC class I binding prediction for unbalanced datasets
by: Tomaras Georgia D, et al.
Published: (2008-09-01)

Identification of RTS,S/AS01 vaccine–induced humoral biomarkers predictive of protection against controlled human malaria infection
by: Rachel L. Spreng, et al.
Published: (2024-10-01)

Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAs.
by: Heather B Miller, et al.
Published: (2009-05-01)

Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques
by: Marina Tuyishime, et al.
Published: (2023-12-01)

Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines
by: Koshlan Mayer-Blackwell, et al.
Published: (2022-10-01)

Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses.
by: Matthew Zirui Tay, et al.
Published: (2016-08-01)

Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience
by: Krishna Mohan Vadrevu, et al.
Published: (2025-12-01)

H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials
by: Sheetal Sawant, et al.
Published: (2023-04-01)

Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein
by: Elaine Thai, et al.
Published: (2023-11-01)

Serpentine Micromixers Using Extensional Mixing Elements
by: George Tomaras, et al.
Published: (2022-10-01)

Defining genetic diversity of rhesus macaque Fcγ receptors with long-read RNA sequencing
by: Haleigh E. Conley, et al.
Published: (2024-01-01)

Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons
by: Gabriel Tremblay, et al.
Published: (2021-02-01)

A blaschkoid birthmark
by: Miranda Tomaras, BA, et al.
Published: (2024-04-01)

Comments on the entropic gravity proposal
by: Sourav Bhattacharya, et al.
Published: (2018-08-01)

Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV
by: Shixia Wang, et al.
Published: (2022-02-01)

Sound attenuation and anharmonic damping in solids with correlated disorder
by: W. Schirmacher, et al.
Published: (2010-01-01)

Aquaponics in Urban Agriculture: Social Acceptance and Urban Food Planning
by: Georgia Pollard, et al.
Published: (2017-06-01)

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques
by: Mohammad Arif Rahman, et al.
Published: (2023-04-01)

Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum.
by: James Friedman, et al.
Published: (2012-01-01)

UAV, GNSS, and InSAR Data Analyses for Landslide Monitoring in a Mountainous Village in Western Greece
by: Konstantinos G. Nikolakopoulos, et al.
Published: (2023-05-01)

Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques
by: Anil Verma, et al.
Published: (2024-02-01)

Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity
by: Junsuke Nohara, et al.
Published: (2025-01-01)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
by: Dieter Mielke, et al.
Published: (2019-12-01)

Reconstructing a B-cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation
by: Thomas B. Kepler, et al.
Published: (2014-04-01)

A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
by: Xiaoying Shen, et al.
Published: (2025-01-01)

Prior human endemic coronavirus exposure does not affect humoral responses to SARS-CoV-2 protein vaccines
by: Guy de Bruyn, et al.
Published: (2025-07-01)

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants.
by: Nicole Espy, et al.
Published: (2023-01-01)

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants
by: Nicole Espy, et al.
Published: (2023-01-01)

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses
by: Ying Huang, et al.
Published: (2024-08-01)

Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
by: Camille N Pierre, et al.
Published: (2024-06-01)

Optimizing human B cell repertoire analyses to interpret clinical data and design sequential HIV vaccines
by: Milton Maciel, et al.
Published: (2025-07-01)

Advancements in surgical modalities for corneal hydrops: A comprehensive review
by: Mohammad-Ali Abtahi, et al.
Published: (2025-09-01)

Quality of life in mentally ill, physically ill and healthy individuals: The validation of the Greek version of the World Health Organization Quality of Life (WHOQOL-100) questionnaire
by: Liappas Ioannis A, et al.
Published: (2009-10-01)